Search Results 781-790 of 13930 for Assay

  1. Clinical trials - Oncology (Medical)

    ... assays using patient peripheral blood immune cells or serum. 3D Ultrasound For The Imaging Of Axillary Lymph Nodes In Patients With Breast Cancer. Rochester ...

  2. Sean J. Pittock, M.D. - Mayo Clinic Faculty Profiles

    Pittock, M.D., lies in modifying, for clinical application, the antibody assays developed by the Neuroimmunology Research Laboratory. Specific areas of ...

  3. Kidney Tumor Clinical Trials - Mayo Clinic Research

    Cohort 1 includes blood collections for in vitro studies which are a component of NIH-funded Project 3 within the Mayo Clinic ... CfDNA Assay Prospective ...

  4. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    Serum free light chain (FLC) assay: involved FLC assay ≥ 10 mg/dL and an abnormal serum FLC ratio (< 0.26 or > 1.65). Patients with RR-NHL must be relapsed ...

  5. Aspartate aminotransferase (AST) blood test - Mayo Clinic

    An AST blood test helps check for liver damage. Learn when the test is done, how to prepare and what the results mean.

  6. Oncoimmune Signaling and Therapeutics - Mayo Clinic Research

    Based on these discoveries, our team is working to develop a clinically viable assay for p95HER2 expression in breast cancer. In addition, we're working ...

  7. Clinical trials - Oncology (Medical)

    ... assays using patient peripheral blood immune cells or serum. 3D Ultrasound For The Imaging Of Axillary Lymph Nodes In Patients With Breast Cancer. Rochester ...

  8. Obstetrics and Gynecology - Clinical trials

    ... assay (IHC) and identified as appropriate for study participation if IHC staining is PS2+ in \>75% of cells (40% of all serous patients). Eligible patients ...

  9. Safety And Preliminary Efficacy Of OBT076 In Recurrent/​Metastatic CD205+ Solid Tumors - Mayo Clinic

    The CD205 assay is a laboratory developed test, validated ... 6) Subject has tumor that is positive for CD205 antigen (≥ 2+ in ≥ 50% IHC) The CD205 assay ...

  10. Clinical trials - Oncology (Medical)

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...